Eli Lilly (NYSE:LLY | LLY Price Prediction) is finally acting like a trillion-dollar drugmaker again. After a brutal stretch ...
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
Zealand Pharma's stock is cratering today after disappointing results from a late-stage trial of its GLP-1 dual-receptor ...
Eli Lilly is leveraging its GLP-1-driven cash flow to build transformative AI and biotech infrastructure, not just dominating ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in ...
FDA approves an extended once-every-eight-weeks maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz) in ...